Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

IIROC Trade Halt - VentriPoint Diagnostics Ltd.

Newsfile March 7, 2014

Ventripoint Announces 510(k) Submission for VMS Heart Analysis System and Issuance of Shares for Debt

Marketwired January 23, 2014

Ventripoint Diagnostics (V.VPT) re-tools for 510(k) re-submit – shares recover 83%

Gaalen Engen December 15, 2013

Ventripoint Announces Regulatory Update for VMS(tm) Heart Analysis System

TheNewsWire December 13, 2013

Ventripoint Announces Planned Response to FDA Notification and Expanded Sales Efforts Outside of the United States

TheNewsWire November 25, 2013

Coastal Energy (T.CEN) up 27% on merger news: Canadian market movers

Elizabeth Walters November 19, 2013

Ventripoint Diagnostics (V.VPT) stock slammed 83% after FDA denial

Chris Parry November 18, 2013

VentriPoint Diagnostics (V.VPT) falls 70% on FDA’s decision: Canadian market movers

Elizabeth Walters November 15, 2013

IIROC Trading Resumption - VPT

Canada NewsWire November 15, 2013

Ventripoint Receives Response from FDA for Application of VMS (tm) for use in Pulmonary Arterial Hypertension

TheNewsWire November 15, 2013

IIROC Trading Halt - VPT

Canada NewsWire November 15, 2013

VentriPoint Diagnostics, Legend Gold and Black Iron Featured on Episode 18 of the Next Biggest Winner TV Show This Weekend

Marketwired November 14, 2013

Ventripoint Announces Increase and Closing Of Debenture Unit Private Placement

TheNewsWire October 22, 2013

Ventripoint Announces Completion of Analysis of Pulmonary Arterial Hypertension Clinical Data and Submission to FDA

TheNewsWire October 7, 2013

Ventripoint Announces Results Of Annual Shareholders' Meeting And Grant Of Stock Options And Deferred Share Units

TheNewsWire October 4, 2013

Ventripoint Announces $300,000 Debenture Unit

TheNewsWire September 27, 2013

Ventripoint Announces Completion Of Analysis Of Pulmonary Arterial Hypertension Clinical Data

TheNewsWire September 26, 2013

Ventripoint Announces Clarification of Terms and Closing of Further $500,000 Debenture Unit Private Placement

Marketwired September 3, 2013

Ventripoint Announces Further $500,000 Unit Debenture Private Placement

Marketwired August 28, 2013

Ventripoint Announces Closing of Debenture Unit Private Placement

Marketwired August 22, 2013